Publications by authors named "Jackson Robinson Mitzner"
JTO Clin Res Rep
June 2021
Article Synopsis
- Immune checkpoint inhibitors (ICIs) are a promising cancer treatment that can have serious side effects, especially in patients with preexisting autoimmune disorders like multiple sclerosis (MS).
- A case study reported significant improvement in a man with both metastatic non-small cell lung cancer (NSCLC) and MS after treatment with atezolizumab, but he also experienced a severe MS flare that stopped further treatment.
- Diagnosing complications in patients with both MS and brain tumors is complicated because symptoms could indicate tumor growth, an MS flare-up, or radiation necrosis, making management difficult.
